Dossa, F.; Baxter, N.N.; Sutradhar, R.; Little, T.; Velsher, L.; Lerner-Ellis, J.; Eisen, A.; Metcalfe, K.
Trends in the Utilization of BRCA1 and BRCA2 Testing After the Introduction of a Publicly Funded Genetic Testing Program. Curr. Oncol. 2025, 32, 439.
https://doi.org/10.3390/curroncol32080439
AMA Style
Dossa F, Baxter NN, Sutradhar R, Little T, Velsher L, Lerner-Ellis J, Eisen A, Metcalfe K.
Trends in the Utilization of BRCA1 and BRCA2 Testing After the Introduction of a Publicly Funded Genetic Testing Program. Current Oncology. 2025; 32(8):439.
https://doi.org/10.3390/curroncol32080439
Chicago/Turabian Style
Dossa, Fahima, Nancy N. Baxter, Rinku Sutradhar, Tari Little, Lea Velsher, Jordan Lerner-Ellis, Andrea Eisen, and Kelly Metcalfe.
2025. "Trends in the Utilization of BRCA1 and BRCA2 Testing After the Introduction of a Publicly Funded Genetic Testing Program" Current Oncology 32, no. 8: 439.
https://doi.org/10.3390/curroncol32080439
APA Style
Dossa, F., Baxter, N. N., Sutradhar, R., Little, T., Velsher, L., Lerner-Ellis, J., Eisen, A., & Metcalfe, K.
(2025). Trends in the Utilization of BRCA1 and BRCA2 Testing After the Introduction of a Publicly Funded Genetic Testing Program. Current Oncology, 32(8), 439.
https://doi.org/10.3390/curroncol32080439
